This is a success message.
This is an error message.
This is also an error message.
Company news

LUMICKS featured in Dutch Tech Heroes Fighting COVID-19

LUMICKS has been featured as one of the 150+ companies in the overview of Dutch Tech Heroes Fighting COVID-19 published by Techleap.nl. The Dutch non-profit organization states:

In the current crisis, the Netherlands is increasingly dependent on digital and technological solutions from startups and scale-ups. It is, therefore, more important than ever that we empower & accelerate the tech companies that help us survive and fight the COVID-19 pandemic.

We thank the Techleap.nl team for this recognition and we will continue working towards our goal: to improve human health by unlocking the power of Dynamic Single-Molecule and Cell Avidity analysis.

We are committing part of our in-house capacity to accept samples and conduct proof-of-concept experiments related to the coronavirus or COVID-19. Find more information here.

Latest news & press

Keep up with everything we’re doing

View all
LUMICKS is collaborating with Amgen to measure Cell Avidity to better understand T-cell engagers
LUMICKS is collaborating with Amgen to measure Cell Avidity to better understand T-cell engagers
Company news
September 30, 2026
01-01-20

This is some text inside of a div block.
LUMICKS Receives Innovation Champion Award at TechEU Equity Summit 2026
LUMICKS Receives Innovation Champion Award at TechEU Equity Summit 2026
Company news
September 25, 2026
01-01-20

This is some text inside of a div block.
2026 SITC Cell Avidity Travel Award
2026 SITC Cell Avidity Travel Award
Company news
July 27, 2026
01-01-20

This is some text inside of a div block.
Cell Avidity Users Highlighted at 2026 Conferences
Cell Avidity Users Highlighted at 2026 Conferences
Company news
April 13, 2026
01-01-20

This is some text inside of a div block.